ChromaDex Corp is a science-based integrated nutraceutical company. The products of the company are devoted at improving human immune function. The company produces dietary supplements, skin care, pharmaceutics, and animal health products.
| Website: | www.chromadex.com |
| Email: | briannag@chromadex.com |
| Main Phone: | +1 310 388-6706 |
| Address: | 10900 Wilshire Boulevard |
| Address 2: | Suite 650 |
| State: | CA |
| City / Town: | Los Angeles |
| Country: | USA |
| Postal Code: | 90024 |
| Exchange: | NSC |
| CEO: | Robert N. Fried |
| Employees: | 100 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
Gathering Data... Please wait ChromaDex Corp is a science-based integrated nutraceutical company. The products of the company are devoted at improving human immune function. The company produces dietary supplements, skin care, pharmaceutics, and animal health products.
| Website: | www.chromadex.com |
| Email: | briannag@chromadex.com |
| Main Phone: | +1 310 388-6706 |
| Address: | 10900 Wilshire Boulevard |
| Address 2: | Suite 650 |
| State: | CA |
| City / Town: | Los Angeles |
| Country: | USA |
| Postal Code: | 90024 |
| Exchange: | NSC |
| CEO: | Robert N. Fried |
| Employees: | 100 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
| Last Price 4.11 | Change $ 0.16 | Change % 4.05 | Tick N/A |
| Bid 0. | Bid Size 0.00 | Ask 0. | Ask Size 0.00 |
| Open 3.99 | High 4.16 | Low 3.95 | Prev Close 3.95 |
| Last Trade | Volume 67,483 | 52 Wk Hi 5.00 | 52 Wk Low 2.79 |
| Market Cap 228.2 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 55,521,783.00 | EPS (TTM) -0.61 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 10 | 19 |
| Number of Buys | 8 | 14 |
| Number of Sells | 2 | 5 |
| Net Activity | 37800 | 383133 |
| Last 10 Buys | Shares |
|---|---|
| Kevin M. Farr | 1,000 |
| Mark J. Friedman | 1,000 |
| Frank L. Jaksch | 1,000 |
| Robert N. Fried | 1,000 |
| Frank L. Jaksch | 1,000 |
| Stephen Allen | 1,000 |
| Robert N. Fried | 1,000 |
| Stephen Allen | 1,000 |
| Stephen Allen | 1,000 |
| Frank L. Jaksch | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Frank L. Jaksch | 1,000 |
| Frank L. Jaksch | 1,000 |
| Frank L. Jaksch | 1,000 |
| Frank L. Jaksch | 1,000 |
| Frank L. Jaksch | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 10.5 | 10.5 | 10.5 | 10.5 |
| Low Target Price Estimate | 8 | 8 | 8 | 8 |
| Mean Target Price Estimate | 9.25 | 9.25 | 9.25 | 9.25 |
| Standard Deviation | 1.77 | 1.77 | 1.77 | 1.77 |
| Date of Most Recent Estimate | 05/24/18 | 05/24/18 | 03/11/18 | 05/24/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-06 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-06-06 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-22 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-17 |
| 4/A | Amendment to a previously filed Form 4 | 1 | 2018-05-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-16 |
| 4/A | Amendment to a previously filed Form 4 | 1 | 2018-05-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 27 | 2018-05-10 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 49 | 2018-05-10 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
